ey0015.10-8 | Continuous glucose monitoring, insulin pumps and artificial pancreas | ESPEYB15
B Karges
, A Schwandt
, B Heidtmann
, O Kordonouri
, E Binder
, U Schierloh
, C Boettcher
, T Kapellen
, J Rosenbauer
, RW Holl
To read the full abstract: JAMA. 2017;318:1358-1366Here, the authors compared the metabolic control in young patients with T1DM with insulin pump therapies versus multiple injection treatment modalities using the data from 30 579 patients younger than 20 years of age of 446 centers in a prospective population-based cohort study. While it is very clear that pump therapy, compared with injection ...